Vimarsana
Biggest News Aggregation in the World

Machine Learning Based Software News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Machine Learning Based Software. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Machine Learning Based Software Today - Breaking & Trending Today

FDA Roundup: April 5, 2024 - Vimarsana News

FDA Roundup: April 5, 2024

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an...

FDA Issues Draft Predetermined Change Control Plan for Machine-Learning-Enabled Device Software Functions | McDermott Will & Emery - Vimarsana News

FDA Issues Draft Predetermined Change Control Plan for Machine-Learning-Enabled Device Software Functions | McDermott Will & Emery

On April 3, 2023, the US Food and Drug Administration (FDA) published its draft guidance, Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial...

Suffocating from Medical Bias - Vimarsana News

Suffocating from Medical Bias

A systems engineering approach to equitable health care solutions

A Discussion of FDA's AI/ML Medical Devices, Part II - Vimarsana News

A Discussion of FDA's AI/ML Medical Devices, Part II

FDA announced several digital health initiatives aimed at improving the agency’s resources and policies governing software and data systems. We will review FDA’s digital health improvement highlights and take a quick look at AI/ML-enabled medical devices.

Coverage of FDA's AI/ML Medical Devices Workshop - Part 2: FDA's Recent Digital Health Initiatives | Mintz - Health Care Viewpoints - Vimarsana News

Coverage of FDA's AI/ML Medical Devices Workshop - Part 2: FDA's Recent Digital Health Initiatives | Mintz - Health Care Viewpoints

In our last post, we took a brief look back through history at FDA’s approach to regulating medical device software and found that there is little distinction from the agency’s...